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Abstract
Background: It is well established that caspase-1 exerts its biological activities through its downstream targets such
as IL-1β, IL-18, and Sirt-1. The microarray datasets derived from various caspase-1 knockout tissues indicated that
caspase-1 can significantly impact the transcriptome. However, it is not known whether all the effects exerted by
caspase-1 on transcriptome are mediated only by its well-known substrates. Therefore, we hypothesized that the
effects of caspase-1 on transcriptome may be partially independent from IL-1β, IL-18, and Sirt-1.
Methods: To determine new global and tissue-specific gene regulatory effects of caspase-1, we took novel
microarray data analysis approaches including Venn analysis, cooperation analysis, and meta-analysis methods. We
used these statistical methods to integrate different microarray datasets conducted on different caspase-1 knockout
tissues and datasets where caspase-1 downstream targets were manipulated.
Results: We made the following important findings: (1) Caspase-1 exerts its regulatory effects on the majority of
genes in a tissue-specific manner; (2) Caspase-1 regulatory genes partially cooperates with genes regulated by
sirtuin-1 during organ injury and inflammation in adipose tissue but not in the liver; (3) Caspase-1 cooperates with
IL-1β in regulating less than half of the genes involved in cardiovascular disease, organismal injury, and cancer
in mouse liver; (4) The meta-analysis identifies 40 caspase-1 globally regulated genes across tissues, suggesting that
caspase-1 globally regulates many novel pathways; and (5) The meta-analysis identified new cooperatively and
non-cooperatively regulated genes in caspase-1, IL-1β, IL-18, and Sirt-1 pathways.
Conclusions: Our findings suggest that caspase-1 regulates many new signaling pathways potentially via its
known substrates and also via transcription factors and other proteins that are yet to be identified.
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Background
Caspase-1, a member of the cysteinyl aspartate-specific
protease caspase family, is present in the cytosol as
pro-caspase-1, an inactive zymogen, and requires the
assembly of cytosolic multi-protein complexes known
as “inflammasome” for proteolytic activation [1]. These
complexes are assembled intracellularly in response to
damage/danger signal-associated molecular patterns
(DAMPs) and pathogen-associated molecular patterns
(PAMPs), therefore, plays a similar role to that of Toll-like
receptors (TLRs) at the cell surface [2]. Activated caspase-
1 is required for cleaving/processing of pro-interleukin-1β
(pro-IL-1β) and pro-IL-18 into mature pro-inflammatory
cytokines IL-1β and IL-18, respectively. Moreover, acti-
vated caspase-1 can induce other inflammatory pathways
by degrading anti-inflammatory sirtuin-1 (Sirt-1), which is
a nicotinamide adenine dinucleotide (NAD)-dependent
protein/class III histone deacetylase [3]. Caspase-1 has
been shown to induce cell necrosis, pyroptosis, or
pyrop-apoptosis [4] and exerts functions in various de-
velopmental stages. All these biological activities of
caspase-1 occur at post-translational level (proteolytic
processing). However, it remains unclear whether
caspase-1 regulates gene transcription independent of
the three well-characterized caspase-1 substrates IL-
1β, IL-18, and Sirt-1.
The regulatory effects of caspase-1 on gene expression
have been reported in the intestine [5], liver [5], and
adipose tissue [6]. TLRs were shown to work in synergy
with cytosolic-sensing receptor families including NLRs
(NOD (nucleotide binding and oligomerization domain)-
like receptors) in recognizing endogenous DAMPs and
in mediating upregulation and activation of a range of
inflammatory genes [7]. We recently reported a series of
significant findings on the expression and roles of cas-
pase-1 in vascular inflammation: (1) NLR, inflammasome
components, and caspases are differentially expressed in
human and mouse tissues [8]; (2) caspase-1 recognizes ex-
tended cleavage sites on its natural substrates [9]; (3) early
hyperlipidemia promotes endothelial activation/dysfunction
[10] via a caspase-1-sirtuin 1 pathway [11]; (4) inhibition of
caspase-1 activation improves angiogenesis [12]; (5)
caspase-1 mediates hyperlipidemia-weakened progenitor
cell [13] vessel repair [14]; (6) caspase-1 mediates chronic
kidney disease-promoted neointima hyperplasia of the ca-
rotid artery [15]; and (7) hyperhomocysteinemia induces
caspase-1-mediated pyrop-apoptosis [4]. However, it re-
mains unknown whether caspase-1 regulates gene
expression in the aorta, which creates a knowledge gap for
characterizing the role played by caspase-1 in promoting
atherogenesis and arterial inflammation.
As we reported previously [8], TLRs and NLRs in
tissues are differentially expressed and based on this
observation, we classified the analyzed tissues in to three
tiers. We categorized tissues such as the brain, lymph
nodes, and thymus in to tier 1 because they constitutively
express inflammasome components indicating their ability
to assemble active inflammasomes rapidly in response to
PAMPs/ DAMPs. Vascular tissue and heart was catego-
rized in to tier 2 and 3, respectively. Tissues in tier 2 re-
quire upregulation of one inflammasome component, and
tier 3 tissues require upregulation of two inflammasome
components to assemble active inflammasomes. This
suggests that unlike tissues in tier 1, tissues categorized in
to tiers 2 and 3 show a delayed caspase-1 activation in
response to PAMPs/ DAMPs. Therefore, we coined the
term “inflammation privilege” for tissues that require
“priming” to assemble active inflammasomes in response
to stress. We emphasize that this delayed caspase-1 activa-
tion is a protective mechanism that increases the thresh-
old for response to mitigate over-sensitivity and excessive
tissue destruction by inflammasome/ IL-1β based innate
immunity response.
One of our previous publications implicated that [9],
in addition to regulatory effects executed by well-
characterized caspase-1 substrates IL-1β, IL-18, and
Sirt-1, caspase-1 (enzyme ID: EC 3.4.22.36) also
cleaves many other protein substrates including those
listed in the Brenda enzyme [16], and deneddylase in-
volved in Epstein-Barr virus replication [17], tran-
scription factors GATA4 [18], and PPARγ [19]. Since
most proteins among 25 identified caspase-1 substrates
are differentially expressed in tissues [9, 17], it remains un-
known whether regulatory effects exerted by caspase-1 on
gene expression via cleaving the gene regulatory sub-
strates, including transcription factors [9], are tissue-
specific. A recent report showed that NLRP3, a well-
characterized NLR, is a transcription regulator of type 2T
helper cell (Th2) differentiation [20] indicating that
inflammasome components also can regulate the gene ex-
pression. Moreover, it was reported that caspase-1 can be
activated in the nucleus [21, 22], suggesting the possibility
that caspase-1 may directly regulate gene expression via
an unknown mechanism. However, direct gene regulatory
effects of caspase-1 remain unidentified.
Traditionally, meta-analysis refers to a statistical method
that focuses upon contrasting and integrating the findings
from the reports by different teams in order to identify
shared patterns whereas these patterns could not be easily
identified with each individual dataset. Meta-analyses have
been widely used in clinical and epidemiological studies
[23]. Recently, meta-analysis approach had also been
applied to analyses of gene expression microarray
data [24]. However, this approach has never been
used to integrate different caspase-1 microarray data-
sets and also to identify novel targets which caspase-
1 may regulate independent of IL-1β-, IL-18-, and
Sirt-1.
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In this report, we hypothesized that caspase-1 regulates
the transcriptomes in a tissue-specific manner, and that
these transcriptional effects are at least partially inde-
pendent from the effects of IL-1β-, IL-18-, and Sirt-1.
To test these hypotheses, we utilized Venn analysis
and meta-analysis to compare our hyperlipidemic
apolipoprotein E (ApoE−/− or ApoE KO) and caspase-1-
deficient mouse aorta microarray data with caspase-1−/−
intestine [5], caspase-1−/− liver [5], and caspase-1−/−
adipose tissue [6] datasets deposited in the NIH-National
Center for Biotechnology Information (NCBI)-Gene Ex-
pression Omnibus (GEO) database. This approach en-
abled us to determine the global and tissue-specific effects
of caspase-1 on transcriptomes. Furthermore, we meta-
analyzed the global transcriptional effects of IL-1β, IL-18,
and Sirt-1 and used scatter plots to detect genes that are
modulated independently or dependently (which we
termed as cooperation analysis) to each other. Our results
have demonstrated for the first time that caspase-1 regu-
lates transcriptomes in both tissue-specific and global
manner. Most strikingly, caspase-1 can regulate gene
expression independently from IL-1β-, IL-18-, or Sirt-1-
regulated pathways globally. In contrast, the caspase-1
function in regulating gene expression is well cooperated
with Sirt-1 pathway in the adipose tissue. The findings will
eventually lead to future development of novel therapeu-
tics for inflammatory diseases.
Methods
Search for the microarray datasets
A thorough search was conducted to identify all the candi-
date datasets in the Gene Expression Omnibus databases
from the NIH-National Center for Biotechnology Informa-
tion and in the ArrayExpress databases from the European
Molecular Biology Laboratory (EMBL)—European Bio-
informatics Institute (EBI). Search terms included cas-
pase1 (or Casp1), interleukin-1 beta (or IL-1β, IL-1βeta,
IL-1β), interleukin-18 (or IL-18), and sirtuin-1 (or Sirt-
1). Our meta-analysis were performed according to the
“Preferred Reporting Items for Systematic Reviews and
Meta-Analyses” guidelines (PRISMA) [25]. The flow
diagram is shown in Additional file 1: Figure S1b. The
details of the datasets that were analyzed are shown in
Additional file 1: Table S1. We applied the following
inclusion criteria for our study as shown in Additional
file 1: Figure S1b: (1) the organism was Mus musculus,
(2) the datasets were the results from RNA microarray
assay experiments, (3) the datasets were derived from
the experiments using transgenic (Tg, gene overexpres-
sion) or gene-deficient mouse samples (gene downregu-
lation and deficiency) of Casp1, IL-1β, IL-18, or Sirt-1,
and (4) the datasets were derived from in vitro studies
with activation or inhibition of Casp1, IL-1β, IL-18, or
Sirt-1. In addition, we applied the following exclusion
criteria for our study: (1) the datasets were derived
from microRNA array; (2) the datasets were derived
from chromatin immunoprecipitation (ChIP) followed
by microarray (ChIP-on-chip), and ChIP followed by
DNA sequencing (ChIP-seq); (3) the datasets were de-
rived from the experiments with sample size less than 2
(statistical parameter p value cannot be generated); and
(4) specific reasons: (a) for example, the GEO dataset
GSE26766 was derived from the experiments, where IL-
1β was injected in intracerebroventricular (ICV) whereas
the RNAs of the skeletal muscle were isolated to run the
expression array and (b) the GEO dataset GSE16104 was
derived from an experiment where IL-1 was treated on
IL-1 receptor knockout mice. The gene expression regula-
tory effect of IL-1 was complexed by IL-1 receptor knock-
out effects in regulating gene expressions.
Analysis of microarray data
Our gene expression data from microarray experiments
with the aorta from five male ApoE−/− and five male
Caspase-1−/−ApoE−/− mice were analyzed in the R statis-
tical environment [26] using “oligo” and “limma” packages
[27, 28] and were deposited in the NIH-GEO database
(GSE72248). Briefly, total RNA was extracted from the
aortas of mice using the RNeasy Kit (Qiagen, Valencia,
CA). Samples were then labeled and hybridized to
Affymetrix Genechip Mouse Gene 2.0.ST Arrays (Santa
Clara, CA) according to the manufacturer’s instructions.
Scanned microarray images were analyzed using the
Affymetrix Gene Expression Console with Robust Multi-
array Average normalization algorithm.
Meta-analysis of gene expression across tissues
To make data extracted from different microarray datasets
comparable, the analysis was conducted on raw data in R
statistical environment (Additional file 1: Figure S1C-1,
Table S1). Differential expression analysis of the experi-
mental group versus the control group in each study was
conducted using scripts modified from GEO2R [29].
Briefly, a design matrix was set up containing the samples
that were to be compared. Differential expression was
tested by lmFit and eBayes function from “limma” package
[28]. P value was adjusted by the Benjamini-Hochberg
method [30]. For each gene in each study, we then calcu-
lated the effect size using the effectsize function from
“metaMA” package [31]. The unbiased effect size and its
variance were combined across multiple studies using the
directEScombi function. P value was calculated from the
combined statistics using normal distribution and adjusted
by Benjamini-Hochberg method [30]. To calculate the
combined fold change for each gene, we meta-analyzed
the fold change across studies by inverse variance
weighting method using metagen function from “meta”
package [32].
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Venn analysis was performed in R statistical environ-
ment using the package “Venn Diagram” to analyze
Casp1-regulated gene expression among different tissues
(Additional file 1: Figure S1C-2). Heat maps and scatter
plots were made using statistical tools provided by the R
and Bioconductor projects. Statistical significance in this
study was set at p < 0.05. Meta-analysis was used to
directly compare datasets derived from different micro-
array datasets. FC/FC ((FC) fold change) scatter plots were
used to determine whether caspase−/−-regulated genes
could cooperate with genes regulated by IL-1β, IL-18, or
Sirt1 as was previously described (from herein referred as
cooperation analysis) [33] (Additional file 1: Figure S1C-
3). For microarray datasets extracted from caspase-1−/−
liver and adipose tissue, direct cooperation analyses with-
out the precedent meta-analyses were performed to deter-
mine whether the caspase-1 regulatory genes cooperate
with IL-1β, IL-18, and Sirt-1 regulatory genes (Additional
file 1: Figure S1C-4).
Results
Caspase-1 regulates the majority of genes in a tissue-
specific manner
We and others have previously shown that caspase-1
mediated activation of TLR and NLR genes and caspase-1
enzymatic substrate genes are differentially expressed in
tissues [8]. Thus, we hypothesized that caspase-1 regulates
gene expression in a tissue-specific manner. To test this
hypothesis, we compared our mouse caspase−/− aorta
microarray dataset with other reported three caspase-1
−/− microarray datasets (both caspase-1−/− mice versus
wild-type (WT) mice) extracted from the adipose tissues,
liver, and intestine (aorta/GSE72248, adipose/GSE25205,
liver/GSE32515, and intestinal/GSE32515). For analyzing
the roles of caspase-1 in different parts of the mouse
intestine, we collected microarray data from different sec-
tions of the intestine including the duodenum, jejunum,
and ileum. Although these microarray datasets were ob-
tained using different microarray platforms from different
tissues or cells, since we used the raw data and conducted
the same analysis as we did with our microarray data, all
the data were statistically comparable. The rationale to
focus on the caspase-1 function in the aorta was because
our recent reports showed that caspase-1 promotes vascu-
lar inflammation and atherosclerosis in the aorta [8, 9, 11,
12, 14]. After summarizing all four normalized datasets,
we found that expression of 11,039 genes were signifi-
cantly changed among 29,753 mapped genes (37.1%)
(Additional file 1: Table S1). Our results showed that the
percentages of changes in gene expression in tissues
ranged from 10.7 to 29.3%, with intestinal 11.1%, liver
13.5%, adipose 29.3%, and aorta 10.7%.
The results generated primarily from microarray data
analysis are lists of genes that are differentially expressed
between different samples utilized for the study. Once
such list is created, identifying the underlying biological
themes and relationships of the altered genes are difficult
without graphical representation. This task becomes more
tedious specifically in a situation where multiple datasets
generated from different microarray datasets have to be
compared. Therefore, in such situations, Venn analysis/
diagram comes as a very useful analytical tool as it helps
to clearly visualize the genes that are shared between the
different treatment groups analyzed. Therefore, we con-
ducted Venn analysis on 15,477 genes that were shared
among these 4 datasets to identify the common genes that
are altered among different tissues (Fig. 1a).
Interestingly, we found that caspase-1 regulates gene
expression differentially in tissues examined. In the
aorta, caspase-1 regulates the expression of 1774 genes,
including (i) 819 genes with the expression changed in
the aorta alone, (ii) 95 genes shared with the intestine,
(iii) 148 genes shared with the liver, (iv) 485 genes
shared with the adipose tissue, (v) 109 genes shared with
the liver and adipose tissue, (vi) 33 genes shared with
the liver and intestine, (vii) 65 genes shared with the
intestine and adipose tissue, and finally, (viii) 20 genes
shared with the intestine, liver, and adipose tissues. The
20 genes that were overlapped/shared among all these 4
tissues suggest that these genes were regulated by
caspase-1 independent of tissue-specific signaling and
different transcriptomic environments. Figure 1b shows
the heat map of the fold changes of these 20 overlapped
genes. Of note, 14 genes regulated by caspase-1 were
either upregulated or downregulated depending on the
tissues, suggesting that the caspase-1 regulatory signals on
those 14 genes are overpowered by the tissue differen-
tiation signals.
Moreover, we conducted Venn analysis on all the
caspase-1-regulated genes in three different types of
intestinal sections (the duodenum, jejunum, and ileum)
(Fig. 1c). As these three types of intestinal tissues are
similar in histology, we found mostly similar effects of
caspase-1 on gene regulation in these tissues. Among
5291, a total of 313 common genes were modulated by
caspase-1 in all the three tissue types. Specifically,
caspase-1 downregulated 149 genes and upregulated 153
genes in all the three intestinal sections. These results
further confirm that caspase-1 play a tissue-specific role
in gene regulation in the three types of intestinal tissues.
Only 5.9% of genes were regulated by caspase-1 in a
non-tissue-specific manner.
Caspase-1 promotes global expression of four
inflammatory genes and inhibits two genes involved in
mitochondrial energy metabolism
In addition to serving as the essential regulator of inflam-
matory cell death (pyroptosis), the deficiencies of either
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caspase-1 or inflammasome components such as NLRP3
and apoptosis-associated speck-like protein containing a
caspase-recruitment domain (ASC) protected from high fat
diet-induced insulin resistance, glucose intolerance,
obesity [34], triglyceride metabolism [35], mitochon-
drial autophagy [36], and metabolic inflammation [37].
However, the mechanisms underlying how caspase-1
regulates these pathways related to metabolism remain
unclear.
Our Venn analysis revealed that caspase-1 regulate 20
genes globally, and out of these 20 genes, only 6 genes
showed the same direction of change: 4 genes including
Fig. 1 The Venn analysis show that caspase-1 gene regulatory effects have strong tissue specificities (direct comparison, non-meta-analysis). a Venn
Diagram analysis of significantly changed genes among four different tissues comparing caspase-1 deletion to wild type. The logical relationships of
caspase-1-regulated gene among four different tissues are shown in this diagram. 1Ts represent specific regulated genes in a single tissue (green arrow
represent downregulated and red arrow represent upregulated), and 2Ts/3Ts/4Ts represent regulated genes in/among two/three/four involved tissues
(−− represent mixed fold changes in involved tissues). b Heat map for fold changes of overlapped genes among four tissues. 1700112E06Rik, Lsm4,
Pyhin1, and Tifa were all significantly downregulated by deletion of caspase-1 among four tissues. Nnt and Phka1 were significantly upregulated
among the four tissues. And the other 14 genes were either upregulated or downregulated in analyzed tissues. c Venn diagram of significantly
changed genes among three different intestinal tissues comparing caspase-1 deletion to WT. d Caspase-1 globally regulated gene expression
are not ubiquitously regulated by two apoptosis pathways. e The major function of the six genes that are regulated by caspase-1 across all
the four tissue types
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Lsm family of RNA-binding protein 4 (Lsm4) [38], cell dif-
ferentiation regulator 1700112E06Rik (C10orf11, a nuclear
protein, containing a leucine-rich repeat-containing do-
main and 4 leucine-rich repeats), tumor necrosis factor
(TNF) receptor-associated factor (TRAF)-interacting pro-
tein with forkhead-associated domain (Tifa—an essential
innate immunity regulator [39] and IL-1 signaling regula-
tor [40]), and pyrin and HIN domain family member 1
(pyhin1—a newly identified asthma susceptibility locus
[41] and a HIN-200 family of interferon-inducible proteins
member) were significantly decreased in all the four
tissues of caspase-1 KO mice, suggesting that caspase-1
activation promotes the activation of these four genes. In
addition, caspase-1 deficiency in four tissues upregulated
the two following genes: (1) nicotinamide nucleotide
transhydrogenase (Nnt) [42], which acts as a regulator of
nicotinate/nicotinamide metabolism, NADPH-generating
enzyme, and mitochondrial membrane potential keeper
[43] and (2) phosphorylase kinase α1 (Phka1) [44], which
regulates calcium signaling, insulin signaling, and also acts
as a myopathy inhibitor [45]. Therefore, this result
particularly indicates that caspase-1 activation inhibits the
expression of these two genes in the four tissues examined
(Fig. 1b).
While caspase-1 is an essential regulator for inflamma-
tory cell death (pyroptosis), caspase-8 and caspase-9 are
necessary components for cell death receptor-mediated
apoptosis pathway and mitochondria-mediated apoptosis
pathway, respectively [46, 47]. However, the downstream
genes and pathways regulated by various caspases
remain poorly characterized. We hypothesized that the
aforementioned six caspase-1 globally regulated genes
may be the hallmark genes of caspase-1-specific path-
ways, independent of other apoptosis regulators such as
caspase-8 and caspase-9. To test this hypothesis, we
cross-examined the expression of the six caspase-1
globally regulated genes in caspase-8 KO caspase-9 KO
tissues. As shown in Fig. 1d, among four caspase-1-
promoted genes (downregulated in caspase-1 KO mice),
caspase-8 also promoted the expression of two genes in-
cluding Tifa and 1700112E06Rik in one of three tissues
(intestinal epithelium) (GSE30873). In contrast, caspase-
9 KO upregulated 1700112E06Rik in the lineage-Kit
+CD45.2+hematopoietic cells (GSE57934). Among the
two caspase-1-inhibited genes (upregulated in caspase-1
KO mice), caspase-8 inhibited phka1 only in the bone
marrow cells. Taken together, our Venn analysis results
suggested that the six caspase-1 globally regulated genes
are not generally modulated by caspase-8-dependent
death receptor apoptosis pathway or by caspase-9-
dependent mitochondria-mediated apoptosis pathway.
Therefore, it is justified that the six genes regulated
globally by caspase-1 can be considered as specific
hallmark genes that indicate caspase-1 activation.
By analyzing the major functions of the six caspase-1
globally regulated genes (Fig. 1e), we suggest several new
pathways where caspase-1 may (1) promote interferon-β
(IFN-β)- and NF-kB-mediated inflammatory pathways,
(2) regulate new RNA degradation pathway, and (3)
inhibit insulin signaling and mitochondrial energy me-
tabolism pathway, which are well correlated with the
reported caspase-1 role in mitochondrial disassembly,
mitochondrial reactive oxygen species generation, dis-
sipation of mitochondrial membrane potential, and in-
hibition of mitophagy etc. [48].
Genes regulated by caspase-1 partially cooperate with
genes regulated by Sirt-1 during organ injury and
inflammation in the adipose tissue but not in the liver
Caspase-1 regulates non-inflammatory lipid/energy me-
tabolism including increasing serum triglyceride levels
[35, 37], decreasing mitochondrial respiration and
protecting hepatocyte death [36], promoting adipocyte
differentiation, and enhancing insulin resistance [49],
which may not all be dependent on the effects of
caspase-1 on histone deacetylase Sirt-1. Therefore, we
hypothesized that the non-inflammatory effects of
caspase-1 are partially independent from that of Sirt-1 in
mouse adipose tissue. Since we found that caspase-1 had
tissue-specific regulatory effects on gene expression, we
examined caspase-1-mediated gene expression in the
adipose tissue in detail.
In order to validate this hypothesis, we extracted
original data from two microarray datasets conducted
on caspase-1 and Sirt-1-deficient mouse adipose tissues
(GSE25205 and GSE30247) (Additional file 1: Table S2).
Then we applied cooperation analysis (explained in the
Methods section) to detect the correlation between
caspase-1 regulatory genes on the same set of genes
regulated by Sirt-1 in the adipose tissue. The fold-
change differences in gene expression between caspase-1
KO and Sirt-1 KO were shown by the Log2 (fold-change,
FC)/Log2 (fold-change, FC) plots using the method pre-
viously reported [50]. Cooperation analysis enables us to
graphically visualize the genes that might be altered due
to direct effect of caspase-1 on Sirt-1 (Fig. 2a). Based on
the fact that active caspase-1 degrades Sirt-1, we
reasoned that if caspase-1 fully uses inhibition of Sirt-1
to regulate gene expression, the genes regulated by
caspase-1 should cooperate with the genes regulated by
Sirt-1, therefore, caspase-1 should be concentrated in
the first quadrant [(I) with the genes increased in
caspase-1 KO (caspase-1-inhibited genes) and the genes
decreased in Sirt-1 KO (Sirt-1-promoted genes)] and in
the third (III) quadrant [genes decreased in Casp1 KO
(caspase-1-promoted genes) and the genes increased
Sirt-1-deficient adipose tissues (Sirt-1-inhibited genes)]
(Fig. 2a). Therefore, the expression of genes that fall in
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to quadrant I and III can be altered due to the cooper-
ation between caspase-1 and Sirt-1; thus, we termed
these genes as “cooperation genes”. The genes that do
not show a direct link between caspase-1 and Sirt-1 fall
in to quadrant II and IV and named as “independent
genes”. This method had been used in a previous publi-
cation to visualize the cooperation of two different pro-
teins on gene regulation [33].
To our surprise, the expressions of most transcripts
regulated in caspase-1 KO and Sirt-1 KO were non-
evenly distributed in the quadrants I and III (Fig. 3b, R2
= 0.0926). The results suggest that the gene transcription
regulatory effects of caspase-1 and Sirt-1 pathways are
collaborated very well, emphasizing that most of the
non-inflammatory effects regulated by caspase-1 is me-
diated via Sirt-1 in the mouse adipose tissue.
Fig. 2 Cooperation analysis shows that among 163 genes that are highly regulated by caspase-1 and Sirt-1 in mouse adipose tissue, caspase-1
and Sirt-1 cooperatively regulates 142 genes (87.1%). a Explanation for the FC/FC plot. Plots distributed in II and IV quadrants represent caspase-1
independently regulated genes from Sirt-1. b Cooperation of Sirt-1 and caspase-1 in the adipose tissue. FC/FC plot comparing Log2 FC of genes
for Sirt-1 KO vs. WT (x-axis) and parallel caspase-1 KO vs. WT (y-axis). Genes with significant expression changes (with fold changes no less than 2)
were gated. Detailed information about these genes was shown in Additional file 1: Table S5. c The top five signatures of cooperation genes
(p < 0.05) reversely regulated by caspase-1 and Sirt-1 in the adipose tissue. d The top five signatures of non-cooperation genes (p < 0.05) in the
adipose tissue
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Caspase-1 and Sirt-1 cooperatively changed the expres-
sion of 142 genes significantly (≥2 folds) (Fig. 2b). Further,
caspase-1 deficiency upregulated only 15 genes (quadrant
I) and downregulated 127 genes (quadrant III), which
were all inversely regulated by Sirt-1 deficiency in the
adipose tissue (Additional file 1: Table S5). In addition, 17
genes uncooperatively changed (both Sirt-1 KO-promoted
and caspase-1 KO-promoted) which is around 10% of all
the 163 significantly changed genes in the cooperative
study of caspase-1 KO and Sirt-1 KO in the adipose tissue.
Fig. 3 Caspase-1 does not cooperate with Sirt-1 in regulating genes in mouse liver. a Explanation for the FC/FC plot. Plots distributed in quadrants II and
IV represent caspase-1 independently regulated genes from Sirt-1. b Cooperation of Sirt-1 and caspase-1 in the liver. FC/FC plot comparing Log2 FC of
genes for Sirt-1 KO vs. WT (x-axis) and parallel caspase-1 KO vs. WT (y-axis). c Significantly changed genes (fold change > 2) regulated by
caspase-1 and Sirt-1 deficiency in mouse liver. d The top five signatures of genes regulated by caspase-1 in cooperation with Sirt-1 in the
liver. e The top five signatures of genes that are regulated by caspase-1 non-cooperatively with Sirt-1 (p < 0.05) in liver
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Moreover, in the quadrant IV, caspase-1 KO decreased the
expression of four genes including Vnn1 (vanin 1, glyco-
sylphosphatidylinositol (GPI) anchor binding, and pan-
tetheine hydrolase activity), Plau (plasminogen activator,
serine-type endopeptidase activity), Mal (T cell differen-
tiation protein, lipid binding, and structural constituent
of myelin sheath), and Sprr1a (small proline-rich protein
1A, structural molecule activity and protein binding,
bridging), which were also inhibited by Sirt-1 KO, sug-
gesting that caspase-1 independently promotes the ex-
pression of these four genes.
Our further studies using Ingenuity Pathway Analysis
software revealed that caspase-1 has a profound effect
on cellular growth, proliferation, death, and survival via
Sirt-1-dependent and Sirt-1-independent pathways in
the mouse adipose tissues (Fig. 2c, d). Additionally, our
analysis implicated that caspase-1-mediated regulation
of cellular functions and maintenance is significantly
cooperated with Sirt-1 pathway in the adipose tissue.
Furthermore, our pathway analysis indicates that caspase-1
can regulate carbohydrate metabolism in the adipose
tissue most likely through an independent pathway not
related to Sirt-1.
Our Venn analysis clearly demonstrated that the ex-
pression of the majority of genes regulated by caspase-1
are tissue-specific. Therefore, we hypothesized that
caspase-1 and Sirt-1 cooperation in gene regulation is
tissue-specific. To test the hypothesis, we applied the
cooperation analysis of the transcriptional regulatory
effects of caspase-1 with the effects of Sirt-1 on the same
set of genes in the liver (Fig. 3a, b). We extracted the
original data from two microarray datasets conducted on
caspase-1- and Sirt-1-deficient (GSE32515 and GSE46895,
respectively) mouse liver (Additional file 1: Table S1 and
S2). The fold-change differences in genes differentially
expressed in caspase-1 KO and Sirt-1 KO are shown by
the Log2 (fold-change, FC)/Log2 (fold-change, FC) plots
using the method reported [50].
In contrast to what we found in the adipose tissue, the
expression of all the genes regulated in caspase-1 KO
liver and Sirt-1 KO liver were evenly distributed in the
four quadrants (R2 = 0.0022) (Fig. 3b). As shown in
Fig. 3c, we did not find any genes with high fold changes
in the cooperative first quadrant (I) and third quadrant
(III). We found only two genes significantly expressed in
the second quadrant (II) including Mt1 (metallothionein
1A, related to copper ion binding and cadmium ion
binding according to the report in the GeneCards data-
base [51] and Lcn2 (lipocalin 2, related to protein homo-
dimerization activity and iron ion binding according to
the report in the GeneCards database). The expression
of these two genes were increased in both Sirt-1 KO
arrays and caspase-1 KO arrays, indicating that the two
genes are inhibited by Sirt-1 and caspase-1 pathways.
Since caspase-1 degrades Sirt-1, these results suggested
that caspase-1 pathway and Sirt-1 pathway do not
significantly cooperate in regulating gene expression in
the liver. As there are no significant differences in the
expression of caspase-1 and Sirt-1 in the liver and adipose
tissue (the GeneCards database), thus the underlying
mechanism that is involved in the tissue-specific cooper-
ation between caspase-1 and Sirt-1 pathways remains
unknown.
Further analyses with the Ingenuity Pathway Analysis
for all the genes that changed significantly (p < 0.05)
showed that caspase-1 and Sirt-1 cooperated in energy
production and molecular transport in the liver (Fig. 3d).
Also, our results indicated that caspase-1 and Sirt-1 can
regulate the genes related to lipid and nucleic acid
metabolism non-cooperatively (Fig. 3e).
Caspase-1 cooperates with IL-1β in regulating less than
half of the gene expression in mouse liver
Similarly, based on the fact that active caspase-1 is re-
sponsible in generating mature IL-1β, we tested whether
caspase-1 fully uses IL-1β in regulating the expression of
the genes. For this analysis, we compared a microarray
dataset conducted on caspase-1 KO vs. WT to a dataset
derived from IL-1β treatment vs. non-treatment. The
caspase-1 regulatory genes that cooperate well with IL-
1β regulatory genes should be concentrated in the first
(I) quadrant where the genes increased in caspase-1 KO
(caspase-1-inhibited genes) and the genes decreased in
IL-1β treatment (IL-1β-inhibited genes) are included.
Also, the third (III) quadrant contain genes decreased in
caspase-1 KO (caspase-1-promoted genes) and IL-1β
treatment-induced genes indicate cooperation between
caspase-1 and IL-1β (Fig. 4a).
Our analysis showed that the expression of all the
genes regulated by caspase-1 deficiency and IL-1β treat-
ment were evenly distributed in the four quadrants in
Fig. 4b (R2 = 2E−05). Among 27 significantly changed
genes with fold changes higher than two in all four
quadrants, caspase-1 and IL-1β significantly cooperated
in regulating only seven genes in the quadrants I and III
in mouse liver (Fig. 4c). Caspase-1 cooperated with IL-
1β and inhibited the expressions of four genes Acnat2
(acyl-coenzyme A amino acid N-acyltransferase 2),
Slc8a1 (Na+/Ca2+-exchange protein 1), Ifi44l (interferon-
induced protein 44 like), and Slc41a3 (solute carrier
family 41 member 3) in the liver (quadrant I). Also,
caspase-1 cooperated with IL-1β in the liver (quadrant
III) to promote the expression of three genes including
Gm13154 (Zinc-finger double domain), Gpx6 (glutathi-
one peroxidase 6), and Slc15a5 (solute carrier family 15
member 5). In addition, caspase-1 inhibited the expres-
sion of 8 genes independently from IL-1β including
Meg3 (maternally expressed 3 (non-protein coding)),
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Fig. 4 (See legend on next page.)
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Hddc3 (HD domain containing 3), Fkbp5 (FK506 binding
protein 5), Cacna1a (calcium channel, voltage-dependent,
P/Q type, alpha 1A subunit), Marveld3 (MARVEL domain
containing 3), Trhde (thyrotropin-releasing hormone
degrading enzyme), Stap1 (signal-transducing adaptor
family member 1provided), and Sdr16c5 (short-chain
dehydrogenase/reductase family 16C) (quadrant II), and
promoted 12 genes independently from IL-1β including
Gas5 (growth arrest-specific 5 (non-protein coding)),
Pttg1 (pituitary tumor-transforming 1), Cyr61 (cysteine-
rich angiogenic inducer 61), Abcd2 (ATP-binding cassette,
subfamily D (ALD), member 2), 4932438A13Rik (RIKEN
cDNA 4932438A13 gene), Adh6-ps1 (alcohol dehydrogen-
ase 6 (class V), pseudogene 1), Sucnr1 (succinate receptor
1), 4930523C07Rik (RIKEN cDNA 4930523C07), Hsd3b3
(hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid
delta-isomerase 3), Fam47e (family with sequence similarity
47 member E), Acly (ATP citrate lyase), and Reg3b
(regenerating islet-derived 3 betaprovided) (quadrant
IV) in the liver.
Further studies using the Ingenuity Pathway Analysis re-
vealed that for all the genes changed significantly (p < 0.05),
caspase-1 and IL-1β are cooperated in the top five signa-
tures in regulating molecular and cellular functions (166
genes, 42.5%) such as protein synthesis, cell morphology,
nucleic acid metabolism, small molecule biochemistry, and
cellular assembly and organization (Fig. 4d). Figures 3e and
4e clearly suggest that the effects of caspase-1 on lipid me-
tabolism, cellular growth, and cellular proliferation do not
rely on either Sirt-1 or IL-1β pathways. Since the expression
of all the genes regulated by caspase-1 deficiency and IL-1β
treatment were evenly distributed in the four quadrants,
our results suggest that the majority of gene regulatory
effects of caspase-1 are independent from that of IL-1β
regulatory pathways in mouse liver.
The meta-analysis identifies 40 caspase-1 globally
regulated genes, suggesting that caspase-1 regulates
many novel pathways across tissues
We demonstrated above that the transcriptional effects
of caspase-1 are tissue-specific. In addition, we found for
the first time that the significant transcriptional effects
of caspase-1 on genes are independent from that of IL-
1β or Sirt-1 pathways in the liver, but are cooperated
with that of Sirt-1 pathway in adipose tissue. Also as
shown in Venn diagrams (Fig. 1a, c), the transcriptional
effects of caspase-1 on one tissue can be shared with
other tissue(s). Therefore, we hypothesized that more
shared/global transcriptional effects of caspase-1 can be
revealed by conducting a meta-analysis on the datasets.
To examine this hypothesis, we performed the meta-
analysis on those data based on p value and effect size
combination with the strategy shown in Fig. 5a. Meta-
analysis is a tool that can effectively use to integrate
independent but related datasets and enables to derive
robust estimation than is possible from the measure
attained from an individual analysis. Further, meta-
analysis provides higher statistical power by increasing
the sample size that allows to detect an overall effect
and also may highlight subtle variations [52]. To explain
how meta-analysis work, we used forest plots to illus-
trate how the expression of two selected genes changed
across six microarrays conducted on different tissues
(Fig. 5b).
The meta-analysis results showed that caspase-1 defi-
ciency globally inhibits the expression of 17 genes (cas-
pase-1-promoted genes) and promotes the expression of
23 genes (caspase-1-inhibited genes) (Fig. 5c). Of note,
three out of four caspase-1 KO-inhibited genes we identi-
fied by Venn analysis was also confirmed by our meta-
analysis. These genes are Tifa, 1700112E06Rik, and Lsm4.
Similarly, the two caspase-1 KO-promoted genes, Phka1
and Nnt identified by Venn analysis were also found by
the meta-analysis. The comparison between the results we
obtained by meta-analysis and Venn analysis suggest that
our meta-analysis was really more inclusive and reveal
much broader global transcriptional effects of caspase-1
than the Venn analysis. Specifically, our meta-analysis
enabled us to identify 40 global caspase-1-regulated genes
while Venn analysis revealed only 6 genes with the
statistical significance (adjusted p < 0.05), indicating
that meta-analysis is more sensitive than the Venn
analysis.
The pathway analysis (Fig. 5d) we conducted suggests
that caspase-1 regulated 40 genes play significant roles
in a variety of functions including cellular function and
maintenance, cell death and survival, cellular comprom-
ise, cell-to-cell signaling and interaction, and molecular
transport. Further, via these molecular pathways,
caspase-1 may induce developmental disorder, hereditary
disorder, metabolic disease, ophthalmic disease, and or-
ganismal injury and abnormalities.
(See figure on previous page.)
Fig. 4 Cooperation analysis shows that among 27 highly regulated genes by caspase-1 and IL-1β in mouse liver, Caspase-1 and IL-1β cooperatively
regulated 7 genes (25.9%). a Explanation for the FC/FC plot. Plots distributed in quadrants II and IV represent genes that are regulated by caspase-1
independently of IL-1β. b Cooperation of IL-1β and caspase-1 in the liver. FC/FC plot comparing Log2 FC of genes for IL-1β treatment vs.
control (x-axis) and parallel caspase-1 KO vs. WT (y-axis). c Represents significantly changed genes (fold change > 2) regulated by caspase-1
and IL-1β in Fig. 5b. d and e. The top five signatures of genes that are regulated by caspase-1 in cooperation with IL-1β in mouse liver (d).
The top five signatures of the genes that are regulated by caspase-1 non-cooperatively with IL-1β (p < 0.05) in the liver




Fig. 5 The meta-analysis identified 40 Caspase-1 globally regulated genes. a Logic flow of introducing meta-analysis. b Forest plot of two selected
genes as examples. c Heat map for fold changes of significantly changed genes among six different tissues comparing caspase-1 deletion to WT.
* Number form Gene database. d The top 5 signatures of 40 caspase-1 globally regulated genes (adj. p < 0.05)
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The literature search conducted until February 2016
showed that the biological functions of three well-
characterized caspase-1 substrates resulted in a large
number of publications in PubMed, with 26,451 for
IL-1β, 7563 for IL-18, and 3206 for Sirt-1. In contrast,
35 out of 40 caspase-1 globally regulated genes are not
extensively studied and have less than 100 publications
in the PubMed. In addition, 9 out of the 35 caspase-1
regulatory genes identified in meta-analysis are novel
genes and no reports specifying their role had been
published so far. There have been only few “remotely
related” publications available on these genes listed in
the NCBI-Gene database. To the best of our knowledge,
we report for the first time the results obtained by meta-
analysis conducted on caspase-1-related microarray data
sets and have identified novel caspase-1 targeted genes
and pathways.
The meta-analysis identified new cooperatively and non-
cooperatively regulated gene caspase-1, IL-1β, IL-18, and
Sirt-1 pathways
We hypothesized that the global transcriptional effects
of IL-1β in various tissues can be revealed by a meta-
analysis. To examine this hypothesis, we performed a
meta-analysis on those datasets based on p value and
effect size combination with the strategy similar to that
shown in Fig. 5a. The three IL-1β-related microarray
datasets were collected from three different mouse
tissues, two of them were IL-1β transgenic (Tg) samples
(from the lung and stomach) compared to WT
(GSE24931 [53] and GSE38075 [54]); and the other one
had IL-1β treated samples (from liver) compared to con-
trol (GSE19272 [55]). In comparison to that in WT mice
and untreated samples, the percentages of genes with
significant expression changes were different in the
range from 9.0 to 38.9% (IL-1β stimulation for 1 h (h) in
the liver 9.0%, IL-1β stimulation for 4 h in the liver
10.8%, Tg-IL-1β in the lung 20.7%, and Tg-IL-1β in the
stomach 38.9%). After the normalization of all the data,
we found 14,650 significantly changed genes (40.0%)
among 36,600 mapped genes. Total 12,285 overlapped
genes were found among these datasets when inter-
sected (Additional file 1: Table S2).
We also analyzed the gene regulatory function of IL-1β
among tissues such as the liver, stomach, and lung. In Fig. 6a
and Additional file 1: Table S10, IL-1β inhibits the expres-
sion of seven genes including Lim2 (lens intrinsic mem-
brane protein 2), Hs3st2 (heparan sulfate-glucosamine 3-
sulfotransferase 2), Cox5b (cytochrome c oxidase subunit
5B), Pde4b (phosphodiesterase 4B), Ascl2 (achaete-scute
family bHLH transcription factor 2), Ehd2 (EH domain-
containing 2), and Scn3a (sodium voltage-gated channel
alpha subunit 3), and promotes the expression of 69 genes
(fold change >1.5, adjust p < 0.05). The pathway analysis
(Fig. 6b) suggest that IL-1β globally regulated 76 genes play
significant roles in various molecular/cellular functions
including cellular movement, cell-to-cell signaling and
interaction, protein synthesis, cellular function and main-
tenance, and cell death and survival, which may also con-
tribute to the development of inflammatory response,
connective tissue disorders, inflammatory disease, skeletal
and muscular disorders, and immunological disease. To the
best of our knowledge, a comprehensive meta-analysis had
not been done on IL-1β-related microarray datasets
deposited in the NCBI GeoProfile database before;
therefore, the IL-1β-mediated signaling pathways we
report here are novel.
Previously, we conducted cooperation analysis to de-
termine the relationship between caspase-1 and IL-1β
regulatory genes in mouse liver (Fig. 4). Following the
same logic, we then applied the cooperation analysis to
determine the global regulatory effects of caspase-1 with
the effects of IL-1β on the same set of genes we identi-
fied through meta-analysis (Fig. 7a, b). The fold-change
differences in gene expression between caspase-1 KO
induced and IL-1β transgene/treatment induced were
shown by the Log2 (fold-change, FC)/Log2 (fold-change,
FC) plots using the method reported [50].
Similar to that in Fig. 4, the expression of all the genes
regulated by caspase-1 KO and IL-1β treatment were
evenly distributed in the four quadrants (Fig. 7a) (R2 =
0.0012). In all the four quadrants, the expression of
seven genes were significantly changed (fold change >2)
by caspase-1 deficiency; and these genes behaved either
cooperatively or uncooperatively with IL-1β treatment
(Fig. 7b). Caspase-1 cooperated with IL-1β and inhibited
the expression of two following genes: (1) Mboat2
(membrane bound O-acyltransferase domain containing
2, that converts lysophosphatidylethanolamine (lysoPE)
to PE and lysophosphatidic acid (lysoPA) to PA) and (2)
Zfp791 (zinc finger protein 791) (quadrant I). Further,
caspase-1 cooperated with IL-1β (quadrant III) and pro-
moted the expression of four genes including Camk2b
(calcium/calmodulin-dependent protein kinase II beta),
Cd200r1 (mediated signaling by GPCR and MHC class
I-mediated antigen processing and presentation), Cfi
(complement factor I, serine-type endopeptidase activity
and scavenger receptor activity), and Syk (spleen tyro-
sine kinase). In addition, we also identified one IL-1β
inhibited but caspase-1-promoted gene 4933413G19Rik
(an uncharacterized protein-coding gene, NCBI database
and GeneCards database). After detailed analysis for the
integrated pathways with all the significantly changed
genes (p < 0.05), we found that caspase-1 and IL-1β are
globally cooperated in regulating cell development, cell
growth and proliferation which may also explain the in-
volvement of the two genes in protein synthesis and
lipid metabolism pathways (Fig. 7c). Furthermore, both
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caspase-1 and IL-1β regulates cell to cell signaling and
interactions via dependent and independent pathways
(Fig. 7c and d). Our pathway analysis further indicates
that caspase-1 and IL-1β, either cooperatively or unco-
operatively exerts a profound effect on metabolism
across tissues by regulating lipid metabolism, amino
acid metabolism, and carbohydrate metabolism.
Similarly, we studied the cooperation between caspase-1
and IL-18 regulatory genes. For this analysis, we utilized
the only available dataset on IL-18 (GSE33627), which was
conducted on murine natural killer cells. Among 20,456
mapped genes, 9519 of them (46.5%) were found to be
significantly changed in this microarray dataset (Additional
file 1: Table S2) [56]. Since there are no caspase-1 datasets
done on murine natural killer cells, we then applied
the cooperation analysis to determine the meta-
analysis-generated global caspase-1 regulatory genes
with the IL-18 regulatory genes in murine natural
killer cells (Fig. 8a and b). The fold-change differences
in gene expression between caspase-1 KO induced and
IL-18 treatment induced were shown by the Log2
(fold-change, FC)/Log2 (fold-change, FC) plots using
the method reported [50]. Similar to that in Fig. 4, the
expression of all the genes regulated by caspase-1 KO
and IL-18 treatment were evenly distributed in the
four quadrants (Fig. 9a) (R2 = 0.0005). In all four quad-
rants, expression of 4 genes were significantly modu-
lated (fold changes >2) by caspase-1 deficiency. The
changes of these genes were either cooperative or un-
cooperative with IL-18 treatment (Fig. 8b). Caspase-1
cooperated with IL-18 and inhibited the expression of
three immunoglobulin variable genes Igkv10-96 (im-
munoglobulin kappa variable 10–96), LOC637260 (Ig
kappa chain V-IV region B17 precursor-like), and Igkv6-
20 (immunoglobulin kappa variable 6–20) (quadrant I).
Furthermore, caspase-1 cooperated with IL-18 (quadrant
III) and promoted the expression of one gene, which is
caspase-4 (murine homolog caspase-11). Of note, a recent
report showed that non-canonical inflammasome activa-
tion of caspase-4/caspase-11 also reciprocally governs the
activation of IL-18 [57].
Interestingly, after detailed analysis for the integrated
pathways with all the significantly changed genes (p <
0.05), we found that caspase-1 and IL-18 globally cooper-
ate to regulate lipid metabolism similar to our finding with
caspase-1 and IL-1β (Fig. 8c). This indicates that caspase-
1 may have a profound effect on lipid metabolism through
IL-1β and IL-18 pathways, suggesting that it might play a
significant role in adipose tissue as well as in meta-
bolic diseases. This is further confirmed by a previous
Down           Up
Fold Change
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Fig. 6 Meta-analysis of IL-1β microarray datasets identified 76 genes that are globally regulated by IL-1β (FC > 1.5). a Heat map for fold changes
of significantly changed genes with adj. p < 0.05 and FC > 1.5 comparing treatment or transgenic of IL-1β to control. b The top five signatures of
IL-1β significantly regulated genes (adj. p < 0.05, FC > 1.5)
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publication where the role of caspase-1 in adipocyte
differentiation and insulin sensitivity had been demon-
strated [49].
Similarly, we conducted cooperation analysis on
globally regulated caspase-1 genes that we identified
through meta-analysis to the same set of genes across
eight Sirt-1-associated datasets. These datasets were
conducted on five different mouse tissue/cells. Five of
them had Sirt-1 heterozygous/homozygous KO sam-
ples compared to WT (GSE46895 [58], GSE30247 [3],
GSE39778 [59], GSE28790 [60], and GSE26425 [61]),
two of them had Tg-Sirt-1 samples compared to WT
(GSE33101 [62] and GSE7407 [63]), and the last
dataset was on Sirt-1-activated sample compared to
control (GSE19102; unpublished). The percentages of
significantly changed genes were different from 0.1 to
33.1%. After normalization of all the analyzed data, we
found 16,196 significantly changed genes (52.0%)
among 31,128 mapped genes. Totally, 9332 overlapped
genes were found among these datasets when inter-
sected (Additional file 1: Table S2).
We demonstrated above that the transcriptional
effects of caspase-1 cooperated well with that of Sirt-1
in mouse adipose tissue but not in mouse liver, sug-
gesting a possibility that Sirt-1 gene regulatory effects
are tissue-specific. To examine this possibility, we
A B
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Fig. 7 Cooperation analysis shows that among the 7 caspase-1 and IL-1β globally regulated genes with >2 fold change, caspase-1 and IL-1β
cooperatively regulate 6 genes (85.7%). a FC/FC plot comparing log2 transformed fold changes (Log2 FC) of genes for meta-Caspase-1 (deletion of
Caspase-1 among six different tissues) vs. wild type (x-axis) and parallel meta-IL-1β (meta-analysis of treatment and transgenic IL-1β) vs. control (y-axis).
b Significantly changed genes with fold changes higher than two among the four quadrants. c Further analysis by Ingenuity Pathway revealed the top
five signatures of the genes regulated by caspase-1 with cooperation of IL-1β. d The top five signatures of the genes that are regulated by caspase-1
non-cooperatively with IL-1β (p < 0.05)
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performed a meta-analysis for identifying global regu-
latory effects of Sirt-1. We identified 28 Sirt-1 globally
regulated genes, including 11 Sirt-1-promoted genes
and 17 Sirt-1 globally inhibited genes (Fig. 9a). Inter-
estingly, most of the genes that are globally regulated
by Sirt-1 regulate carbohydrate metabolism. Further-
more, these genes are involved in regulating cell cycle,
cell death and survival, morphology and cellular
assembly. This data indicates that the tissue specificity
seen in caspase-1 may be also due to the tissue-
specific functions associated with its substrates as
well.
We then applied the cooperation analysis to determine
the meta-analysis-generated global regulatory effects of
caspase-1 with the global regulatory effects of Sirt-1.
The results in Fig. 10 showed by the Log2 (fold-change,
FC)/Log2 (fold-change, FC) plots using the method re-
ported [50], that the expression of all the meta-analyzed
genes regulated by Casp1 KO and Sirt-1 treatment were
evenly distributed in the four quadrants (R2 = 0.0052). In
all four quadrants, there were no significant expression
changes of genes (fold change >2) and these genes were
found to be regulated either with or without cooperation
between caspase-1 and Sirt-1.
A B
C D
Fig. 8 Cooperation analysis shows that caspase-1 and IL-18 cooperatively regulated all of the four genes that had significant expression changes.
a FC/FC plot comparing Log2 FC of genes for meta-caspase-1 (deletion of caspase-1 among six different tissues) vs. wild type (x-axis) and parallel
IL-18 stimulation vs. control (y-axis). b Significantly changed genes with fold changes higher than two among the four quadrants. c/d The top five
signatures of genes that are regulated by caspase-1 cooperatively with IL-18 and non-cooperatively (p < 0.05)
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Discussion
Recent progress has clearly demonstrated that caspase-
1/inflammasome pathway plays a critical role in regulat-
ing innate immune system by sensing PAMPs and
DAMPs, induce pro-inflammatory cytokine maturation,
promote inflammatory cell death (pyroptosis), induce
histone modification and unconventional secretion, in-
hibits glycolysis, and regulate cell survival [7, 64]. In
addition, myocardial-specific overexpression of caspase-
1 induces a significant increase in cardiomyocyte death
in young mice without any increase in tissue or plasma
levels of IL-1β or other inflammatory mediators [65].
How caspase-1 regulates such broad biological functions
is yet unknown.
Traditionally, signal transduction is realized by kinase-
mediated protein phosphorylation and phosphatase-
mediated de-phosphorylation. Recent progress has shown
that proteases can also function as important regulators in
signal transduction [66] with several important features
including: (i) substrate specificity, (ii) nonreversible signal
transduction, (iii) non-transcription- and non-translation-
dependent, and (iv) non-stable protein complexes for pro-
tease-substrate interactions, etc. We [9] and others
have previously shown that caspase-1 is functional as a
Fig. 9 The meta-analysis of Sirt-1 microarray data identified 28 Sirt-1 globally regulated genes. a Heat map for fold changes of significantly
changed genes with adj. p< 0.05 comparing Sirt1 KO to WT or comparing control to treatment or transgenic of Sirt-1. b The top five signatures of Sirt-1
globally regulated genes as revealed by Ingenuity Pathway Analysis (adj. p< 0.05)
Li et al. Journal of Hematology & Oncology  (2017) 10:40 Page 17 of 23
proteinase and can cleave as many as 59 [67] to 121
[68] experimentally identified protein substrates, poten-
tially cleaves 509 protein substrates encoded by human
genome [69]. Therefore, caspase-1-regulated biological
functions are broader than that carried out by three well-
characterized substrates including two pro-inflammatory
cytokines IL-1β, IL-18, and histone deacetylase Sirt-1. For
example, it has been found that caspase-1 can also regu-
late nuclear translocation of novel anti-inflammatory cyto-
kine IL-37 [70] (previously termed IL-1F7) [9], activation
of sphingosine kinase 2 [71], maturation of Toll-like
receptor adaptor Mal [72], and secretion of retinoic acid-
inducible gene-I [73]. All these attributed functions of
caspase-1 was mediated independently form IL-1β, IL-18,
and Sirt-1.
In order to determine new tissue-specific and global
gene regulatory functions of caspase-1, we took a novel
microarray data analysis approach using Venn analysis,
cooperation analysis, and meta-analysis methods. Based
on the results from our analysis, we have made the
following important findings: (1) Caspase-1 regulatory
effects on majority of genes are tissue-specific. Partly,
A
B C
Fig. 10 Cooperation analysis shows that Sirt-1 and caspase-1 do not cooperate in regulating genes with high fold expression changes. a FC/FC
plot comparing Log2 FC of genes for meta-Sirt-1 (deletion of Sirt-1 vs. WT or control vs. transgenic Sirt-1 or Sirt-1 treatment) (x-axis) and parallel
meta-Caspase-1 KO vs. WT (y-axis). b and c. Further analysis by Ingenuity pathway revealed the top 5 signatures regulated by genes that are
cooperated with caspase-1 and Sirt-1 (b) and the pathways regulated by non-cooperation genes (c) (p < 0.05)
Li et al. Journal of Hematology & Oncology  (2017) 10:40 Page 18 of 23
the tissue specificity we observed with caspase-1 may be
due to tissue specificity seen with its substrate-like Sirt-1
(Fig. 10). Also, the tissue specificity of caspase-1 regula-
tory effects on genes that we observed may be due to
differential expression of inflammasome components in
various tissues as we previously reported [8]; (2) Our
Venn analysis revealed that caspase-1 promotes the
expression of four inflammatory genes and inhibits the
expression of two genes that regulate mitochondrial
energy metabolism globally; (3) Caspase-1 partially co-
operates with Sirt-1 in gene regulation of organ injury
and inflammation in the adipose tissue but not in the
liver; (4) Caspase-1 cooperates with IL-1β in regulating
less than half of the gene expression in mouse liver; (5)
The meta-analysis identifies 40 caspase-1 globally regu-
lated genes, suggesting that caspase-1 regulates many
novel pathways; and (6) The meta-analysis identified
new cooperatively and non-cooperatively regulated genes
in caspase-1, IL-1β, IL-18, and Sirt-1 pathways.
As we previously mentioned in the Results section,
meta-analysis of microarray data allows us to perform an
integrative data analysis to synthesize and review the
results from datasets that are independent but related
[52]. In contrast to traditional analysis of a single set of
microarray data, meta-analysis of microarray datasets has
many benefits including increased sample size and statis-
tical power, leading to integration-driven discovery [74].
Previously, Arasappan et al. had successfully used meta-
analysis to group disparate microarray datasets to identify
gene signature in mononuclear cells withdrawn from
patients with systemic lupus erythematosus [24]. To the
best of our knowledge, this is the first time that meta-
analysis has ever been used to group caspase-1-, IL-1β-,
IL-18-, and Sirt-1-related microarray datasets. Therefore,
our methods used and the conclusions that are drawn in
this study are innovative in determining new caspase-1-
regulated signal pathways.
Our data indicates that caspase-1 is involved in a myriad
of signaling pathways that regulate various cellular func-
tions and pathologies, further emphasizing that caspase-1
exerts its effects independently of its well-known sub-
strates. Previous publications have shown that caspase-1
deficiency can alter the gene expression in various tissues.
Moreover, nuclear localization of caspase-1 and inflamma-
some components, and also formation of active nuclear
inflammasomes in response to viral infections and TNF-α
was previously demonstrated [21, 75]. These active inflam-
masome complexes may generate active caspase-1 in the
nucleus, which may degrade nuclear transcription factors
and histone modifiers that may subsequently alter the
gene expression. In line with these observations, we also
recently reported that substrates and interaction proteins
of caspase-1 are localized in subcellular compartments
other than the cytosol [76]. In this study, we analyzed 114
caspase-1 substrates and 38 caspase-1 interaction proteins
which were all experimentally verified in recent publica-
tions [67, 68]. We reported that out of the 114 identified
caspase-1 substrates, 28 were predominantly localized in
the nucleus. Most interestingly, 14 out of these 28 nuclear
caspase-1 substrates were shown to act as transcription
factors. Similarly, we identified that 7 out of 38 identified
caspase-1 interaction proteins are highly localized in the
nucleus. Together, all these publications provide ample
evidence that caspase-1 has the potential to make a sig-
nificant impact on gene regulation.
Other than caspase-1, inflammasome component NLRP3
can function as a transcription factor in inflammasome-
independent manner for type 2T helper cell (Th2)
polarization [20]. Furthermore, Kerur et al. demonstrated
that an active inflammasome comprised of ASC, IPAF and
caspase-1 was formed in the nucleus in dermal endothelial
cells in response to Kaposi sarcoma-associated viral infec-
tion [75]. Additionally, our most recent publication also
suggested that out of 20 NLRs, 6 NLRs including NLRP3
and IPAF can localize in the nucleus suggesting the possi-
bility of assembling variety of inflammasome complexes in
response to different stresses [76]. Therefore, assembly of
different inflammasome complexes that depend on the cell
type and the nature of the cellular stress might contribute
to the tissue-specific gene regulatory effects of caspase-1
indicated in this study. These variety of inflammasome
complexes may differ in potency and rate to cleave caspase-
1 and also may have different downstream targets resulting
in distinct outcomes that may contribute to tissue-specific
effects. Of note, the differential expression of caspase-1
substrates and interaction proteins also may play a role in
tissue-specific gene regulatory effects of caspase-1.
Also, previously, it was shown that caspase-1 can exert
biological effects independent of its protease activity. Fur-
thermore, caspase-1 non-catalytic function in regulating 77
leaderless secretory proteins including IL-1β was reported
[77, 78]. As we mentioned in the introduction, we catego-
rized the tissues in to three tiers depending on the rate of
inflammasome assembly in response to stress. We identi-
fied tissues in tier 1 that can assemble inflammasomes
rapidly as the constituents that are required for inflamma-
some formation are readily available. Our most recent pub-
lication also reported that caspase-1 interaction proteins
and substrates are also found in extracellular vesicles [76].
Therefore, it is possible that tissues in tier 1 may propagate
inflammation to “inflammation privileged” (tissues that
show a delayed inflammasome assembly) tissues via extra-
cellular vesicles by transporting caspase-1 substrates, inter-
action proteins, and active inflammasomes to regulate gene
expression and also to develop a rapid inflammatory
response. Previous work had also experimentally veri-
fied the presence of active inflammasomes in extracel-
lular vesicles [78–81].
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These evidence suggest that caspase-1 may regulate
gene expression via unidentified non-canonical pathways
as well. Therefore, we emphasize the need for experimen-
tal verification of novel caspase-1 cytosolic and nuclear
substrates. Also, our findings highlight the complexity of
caspase-1 signaling in biological systems and requirement
of elucidating exact mechanisms of how caspase-1 regu-
lates gene expression in the cells.
As illustrated in Fig. 11, the results we obtained from
our analysis point out a possible new functional model
for caspase-1 in regulating gene expression. First, in
response to the stimulation of DAMPs and PAMPs,
caspase-1 becomes activated in the inflammasome com-
plex. Activated caspase-1 converts pro-IL-1β and pro-
IL-18 to mature pro-inflammatory IL-1β and IL-18, re-
spectively. These two cytokines will magnify the inflam-
mation via IL-1β and IL-18 receptor signaling to
upregulate secondary pro-inflammatory genes. Second,
caspase-1 translocate to the nucleus via its pro-domain
[21], cleaves histone deacetylase Sirt-1 that leads to
histone acetylation, downregulates Sirt-1-mediated acti-
vated genes, and increases the expression of genes that
are inhibited by Sirt-1. Third, in addition, caspase-1 can
fulfill its additional IL-1β, IL-18-, and Sirt-1-independent
biological functions via cleaving other transcriptional
factors and master protein in the nucleus that are yet to
be identified. Recently, GATA4, which is a transcription
factor, was identified as a caspase-1 substrate [18].
Traditionally, the enzymatic functions of proteases
are tested by using their substrates as an indirect
probe. Due to restrains such as time, lack of special
instruments, and expertise, and also due to various
tissue-specific expression patterns of substrates and
physical accessibility of substrates under pathophysio-
logical conditions, identification of all the substrates
for caspase-1 is time consuming, laborious, and an
expensive task. The approach utilized in this study
used new angles to determine the biological functions
of caspase-1 by examining the gene regulatory effects
across tissues and comparing to that being regulated
by three well-characterized substrates of caspase-1.
Therefore, herein, we have demonstrated a new approach
to determine the biological outcomes of protease-based
signal transduction. Our findings may eventually lead to
development of novel therapeutics for many inflammatory
and non-inflammatory diseases.
This work was hypothetically driven and conducted
using experimentally generated data available in public
databases. It is our belief that this type of study signifi-
cantly contribute to scientific progress, especially during
the initial stages of identification of downstream targets
and also inducing a paradigm shift in already established
Fig. 11 A novel working model for caspase-1-mediated gene expression. (I) In response to DAMPs and PAMPs, caspase-1 activates IL-1β and
IL-18 which in turn will magnify the inflammation by enhancing secondary pro-inflammatory genes. (II) Caspase-1 may get localized to the
nucleus in response to stress leading to degradation of histone modifier Sirt-1. This may lead to activation of genes that are suppressed by Sirt-1.
(III) Caspase-1 can regulate gene expression by mechanisms that are independent to the mechanisms mediated by its downstream targets IL-1β,
IL-18, and Sirt-1
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scientific models. We acknowledge that our analysis
were done solely on microarray datasets and that it may
not necessarily reflect the protein expression changes of
the targets identified. Therefore, we emphasize the need
for future experimental verification of the caspase-1
downstream targets identified in this study.
Conclusions
We have used meta-analysis to successfully integrate the
data derived from caspase-1-, IL-1β-, and Sirt-1-related
microarray datasets. Based on our results, we conclude
that caspase-1 can exert a profound effect on the tran-
scriptome in a tissue-specific manner and caspase-1-
regulated genes partially cooperate with genes regulated
by its well-known downstream targets. Furthermore, our
meta-analysis revealed as many as 40 genes that are
potentially regulated by caspase-1. Based on the current
and our most recent publications, we conclude that
caspase-1 can exert a major impact on gene regulation
via its nuclear substrates where many seem to play a role
as transcription factors. Also, tissue specificity of caspase-
1 gene regulatory effects may be due to the assembly of a
variety of inflammasome complexes depending on the
cellular context and the nature of the stress. Also, differ-
ential expression of caspase-1 substrates and interaction
proteins also may contribute to tissue specificity of
caspase-1 function.
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